buyModerate
Ew Healthcare Partners Fund 2, L.p. bought $3.0M of TELA
owner, other at TELA Bio, Inc.. 326,062 shares at an average of $9.32, traded Apr 1, 2020, filed Feb 16, 2024.
Conviction score
46Value
$3.0M
326,062 shares
Holdings after
3,610,709
+28% from before
From 52-week low
+48%
low $5.39, close $7.97
From 52-week high
-57%
high $18.33, as of Apr 1, 2020
Score components
- +12Role10% owner
- +25Trade size$3.0M at market
- +6Relative to holdingsHoldings up 28%
- +8Price context57% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
TELAOct 12, 2026 · close 1.08
Since filing Feb 16, 2024: -85.2%SPY +60.9% · excess -146.0%
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-016357, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 1, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +15,000 | $7.47 | $112k | 1,169,231 | Feb 16, 2024 |
| Apr 2, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +15,000 | $8.01 | $120k | 1,184,231 | Feb 16, 2024 |
| Apr 3, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +9,634 | $8.01 | $77k | 1,193,865 | Feb 16, 2024 |
| Apr 6, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +17,866 | $8.10 | $145k | 1,211,731 | Feb 16, 2024 |
| Apr 7, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +20,000 | $8.20 | $164k | 1,231,731 | Feb 16, 2024 |
| Apr 8, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +15,000 | $8.37 | $126k | 1,246,731 | Feb 16, 2024 |
| Apr 9, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +25,000 | $8.47 | $212k | 1,271,731 | Feb 16, 2024 |
| Apr 13, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +10,000 | $7.96 | $80k | 1,281,731 | Feb 16, 2024 |
| Apr 14, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +15,000 | $8.07 | $121k | 1,296,731 | Feb 16, 2024 |
| Apr 15, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +12,500 | $7.99 | $100k | 1,309,231 | Feb 16, 2024 |
| Apr 16, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +17,500 | $8.00 | $140k | 1,326,731 | Feb 16, 2024 |
| Apr 17, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +25,000 | $8.25 | $206k | 1,351,731 | Feb 16, 2024 |
| Apr 20, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +7,000 | $8.06 | $56k | 1,358,731 | Feb 16, 2024 |
| Apr 21, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +3,037 | $8.32 | $25k | 1,361,768 | Feb 16, 2024 |
| Apr 22, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +10,000 | $9.14 | $91k | 1,371,768 | Feb 16, 2024 |
| Apr 23, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +15,000 | $9.98 | $150k | 1,386,768 | Feb 16, 2024 |
| Apr 28, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +5,000 | $9.48 | $47k | 1,391,768 | Feb 16, 2024 |
| Jul 28, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +10,000 | $12.48 | $125k | 1,401,768 | Feb 16, 2024 |
| Jul 29, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +12,600 | $12.39 | $156k | 1,414,368 | Feb 16, 2024 |
| Jul 30, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +7,400 | $12.22 | $90k | 1,421,768 | Feb 16, 2024 |
| Jul 31, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +31,825 | $11.86 | $377k | 1,453,593 | Feb 16, 2024 |
| Aug 3, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +1,400 | $11.86 | $17k | 1,454,993 | Feb 16, 2024 |
| Aug 4, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +10,200 | $12.72 | $130k | 1,465,193 | Feb 16, 2024 |
| Aug 11, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +821 | $12.95 | $11k | 1,466,014 | Feb 16, 2024 |
| Aug 14, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +9,179 | $12.95 | $119k | 1,475,193 | Feb 16, 2024 |
| Aug 28, 2020 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +100 | $12.85 | $1,285 | 1,475,293 | Feb 16, 2024 |
| Jul 14, 2022 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Remarks | +5,000 | $8.01 | $40k | 3,610,709 | Feb 16, 2024 |
Related signals
Other insiders at TELA Bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | TELAbuy TELA Bio, Inc. | Joseph H Capper director | $89k 75,000 shares | +72% | |
| 34Weak | TELAbuy TELA Bio, Inc. | Joseph H Capper director | $78k 75,000 shares | +251% | |
| 38Weak | TELAbuy TELA Bio, Inc. | Heather C Getz Chief Executive Officer | $8,311 12,500 shares | +2% | |
| 33Weak | TELAbuy TELA Bio, Inc. | Heather C Getz Chief Executive Officer | $10k 15,000 shares | +3% | |
| 50Moderate | TELAbuy TELA Bio, Inc. | Ew Healthcare Partners Fund 2, L.p. owner, other | $4.0M 3,604,000 shares | +88% | |
| 58Moderate | TELA Bio, Inc. | Roberto Cuca COO and CFO | $145k 64,444 shares | +71% | |
| 33Weak | TELA Bio, Inc. | Gregory A. Firestone Chief Commercial Officer | $15k 6,666 shares | +13% | |
| 58Moderate | TELA Bio, Inc. | Antony Koblish Chief Executive Officer | $200k 88,888 shares | +24% | |
| 43Moderate | TELA Bio, Inc. | Paul Talmo Chief Technology Officer | $50k 22,222 shares | +32% | |
| 26Weak | TELAbuy TELA Bio, Inc. | Gregory A. Firestone Chief Business Officer | $15k 2,600 shares | +8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.